To describe a fluoroless catheter ablation approach for right-sided supraventricular tachycardia (SVT) and evaluate its implementation in clinical practice.
Approach:
Patient Population: 86 consecutive patients underwent ablation using a fluoroless strategy between May 2024 and April 2025.
Technology Utilized: The CARTO™ 3 electroanatomic mapping system was employed to guide the ablation procedures.
Procedure Details: The approach involved anatomical mapping and ablation without fluoroscopy, using various catheters and techniques for venous access.
Key Findings:
Zero-fluoroscopy interventions are feasible, efficient, and safe.
The use of electroanatomic mapping systems significantly reduces the need for fluoroscopy.
Eliminating radiation exposure also reduces the risk of orthopedic injuries associated with lead aprons.
Interpretation:
The findings support the feasibility and safety of fluoroless catheter ablation techniques for right-sided SVT.
Limitations:
The study is retrospective and may be subject to selection bias.
The sample size is limited to 86 patients.
Conclusion:
The fluoroless approach for right-sided SVT ablation is a viable alternative to traditional methods involving fluoroscopy.
